Abstract

A 12‐week double‐blind study involving individuals with alcohol use disorder has found that the alpha‐1 adrenergic receptor antagonist prazosin reduced the likelihood of heavy drinking relative to placebo. Prazosin did not reduce the frequency of drinking as measured by the number of drinking days per week.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.